Formosa Laboratories, Inc.

NT$43.75As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4746Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (4.17%)
Div yield 6.86%
ROE 4.66%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.46
PE TTM 11.17
TSR TTM (25.28%)
Mkt cap NT$5.261B
ROIC 5.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$48
8.71%
(66.68%)
Hold 5|5|1|12|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.51
0.49
0.49
0.52
14.34%
14.76%
8.64%
4.06%
RevenueNT$M
240.5
235.3
248.9
245.8
1.17%
(2.05%)
0.25%
(0.15%)
Peers (US$158.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
8.046
0.150
0.124
EBIT/Intx
1.052
1.157
0.836
Own earn%
123.29
(246.74)
(234.28)
Sh yield%
28.01
32.12
29.61
Owners
Insiders/Inst%
6.61
66.19
Short interest%
4.78
SBC / revenue%
1.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–7
$1 testx
—
Incr. ROIC%
12